Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Cardiology

How Often Is Cardiac Monitoring Needed in Friedreich Ataxia?

At a Glance

People with Friedreich ataxia typically receive a baseline ECG and echocardiogram at diagnosis. Stable patients are often retested yearly, but the cardiologist may shorten the interval for symptoms, abnormal heart findings, known cardiomyopathy, or pregnancy.

At diagnosis, standard guidelines recommend a baseline cardiac assessment. For stable patients without symptoms, many clinics repeat these tests annually. However, your exact schedule will be individualized by your cardiologist based on your test results and symptoms.

Baseline Testing

Because heart involvement is very common in Friedreich ataxia (FRDA) and a leading cause of health complications, standard clinical guidelines recommend a baseline cardiology evaluation when you are diagnosed [1][2]. This evaluation should include a clinical exam and two key tests:

  • 12-lead electrocardiogram (ECG): A quick, painless test that records your heart’s electrical signals to check for abnormal rhythms.
  • Transthoracic echocardiogram: An ultrasound of the heart that evaluates its structure (such as the thickness of the heart walls) and its pumping function (often measured as the ejection fraction, which is the percentage of blood the heart squeezes out with each beat) [1].

Routine Ongoing Monitoring

Even if your heart is healthy at diagnosis, ongoing follow-up is an essential part of your care because cardiac complications are a major contributor to illness and mortality in FRDA [2]. Heart wall thickness and ejection fraction can change gradually over time [3].

To catch these changes early, doctors rely on repeat ECGs and echocardiograms. While clinical reports and standard practice often involve annual testing for stable patients [4], the 2022 clinical management guidelines emphasize that your schedule should be individualized based on your specific health status and local practices [5]. It is highly recommended to have these tests overseen by a cardiologist who is familiar with inherited cardiomyopathies or neuromuscular diseases.

When Closer Surveillance is Needed

Your cardiologist will recommend more frequent evaluations if you develop new symptoms or if tests show abnormalities [5]. You may need a shorter monitoring interval or medication adjustments if you have:

  • Arrhythmias (irregular heartbeats) [6].
  • A decreased ejection fraction or thickened heart walls on your echocardiogram [3][6].

In certain situations, your cardiologist may use additional, specialized tests to guide your care:

  • Ambulatory rhythm monitoring (Holter monitor): A wearable device that records your heart rhythm for 24 hours or longer, used to detect intermittent arrhythmias [7].
  • NT-proBNP: A blood test that can measure heart strain. Elevated levels may indicate a need for closer monitoring, but this test is used selectively and interpreted alongside other clinical findings [8].
  • Cardiac MRI: An advanced imaging scan that can detect early myocardial fibrosis (scarring in the heart muscle). This is not a routine test for everyone, but may be used when your doctor needs a clearer picture of your heart tissue [9].

Pregnancy Planning and Monitoring

If you are planning to become pregnant, you should schedule a preconception review with a cardiologist or maternal-fetal medicine specialist. If you become pregnant and have known cardiomyopathy (heart muscle disease), specialized guidelines recommend an ECG and echocardiogram at baseline and during every trimester [10]. If your heart function is normal, your monitoring schedule will be individualized by your care team.

When to Seek Immediate Help

Heart function can change between scheduled appointments, and FRDA-related fatigue can sometimes make these changes hard to notice [4].

Call emergency services (like 911) immediately if you experience:

  • Severe or persistent chest pain or pressure.
  • Severe breathing difficulty or blue/gray lips.
  • Fainting or near-fainting, especially when accompanied by a sustained, very rapid, or irregular heartbeat.

Contact your cardiology team the same day if you notice new or worsening (but not life-threatening) symptoms, such as:

  • Shortness of breath during your normal daily activities.
  • Unexplained, rapid weight gain or new swelling in your legs.
  • A fluttering feeling in your chest or occasional heart palpitations.
  • A sudden decrease in your exercise tolerance.

Do not wait for your next scheduled appointment to report these changes.

Common questions in this guide

How often should I have heart tests if I have Friedreich ataxia?
An ECG and echocardiogram are recommended at diagnosis. If you are stable and have no symptoms, many clinics repeat them yearly, but your cardiologist should tailor the schedule to your results and symptoms.
What happens during the first heart evaluation for Friedreich ataxia?
The evaluation usually includes a clinical exam, a 12-lead ECG, and a transthoracic echocardiogram. The ECG checks the heart’s electrical rhythm, while the echocardiogram looks at heart structure, wall thickness, pumping function, and ejection fraction.
Why might my cardiac tests need to be done more often?
New symptoms, irregular heartbeats, thickened heart walls, or reduced pumping function can lead to a shorter testing interval. Depending on your situation, a cardiologist may also use a wearable rhythm monitor, an NT-proBNP blood test, or cardiac MRI.
Which symptoms mean I should get urgent help?
Call emergency services immediately for severe or persistent chest pain or pressure, severe breathing difficulty, blue or gray lips, or fainting, especially with a sustained rapid or irregular heartbeat. Contact your cardiology team the same day for new or worsening shortness of breath, sudden weight gain, leg swelling, palpitations, or reduced exercise tolerance.
What cardiac monitoring is needed during pregnancy with Friedreich ataxia?
If you are planning a pregnancy, arrange a preconception review with a cardiologist or maternal-fetal medicine specialist. If you have known cardiomyopathy, specialized guidance recommends an ECG and echocardiogram at baseline and during every trimester; if heart function is normal, your care team will individualize the schedule.

Get notified when new evidence is published on Friedreich ataxia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Autonomic function testing in Friedreich's ataxia.

    Indelicato E, Fanciulli A, Ndayisaba JP, et al.

    Journal of neurology 2018; (265(9)):2015-2022 doi:10.1007/s00415-018-8946-0.

    PMID: 29951702
  2. 2

    A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.

    Pousset F, Legrand L, Monin ML, et al.

    JAMA neurology 2015; (72(11)):1334-41 doi:10.1001/jamaneurol.2015.1855.

    PMID: 26414159
  3. 3

    Predictors of Left Ventricular Dysfunction in Friedreich's Ataxia in a 16-Year Observational Study.

    Legrand L, Diallo A, Monin ML, et al.

    American journal of cardiovascular drugs : drugs, devices, and other interventions 2020; (20(2)):209-216 doi:10.1007/s40256-019-00375-z.

    PMID: 31650522
  4. 4

    Early onset development of hypertrophic cardiomyopathy in less than 1 year in a patient with familial Friedrich's ataxia: Case report.

    Ouaddouh Y, Bouyaddid S, Bazid Z, et al.

    Radiology case reports 2025; (20(6)):3016-3020 doi:10.1016/j.radcr.2025.03.001.

    PMID: 40224233
  5. 5

    Clinical management guidelines for Friedreich ataxia: best practice in rare diseases.

    Corben LA, Collins V, Milne S, et al.

    Orphanet journal of rare diseases 2022; (17(1)):415 doi:10.1186/s13023-022-02568-3.

    PMID: 36371255
  6. 6

    Predictors of Survival in Friedreich's Ataxia: A Prospective Cohort Study.

    Indelicato E, Reetz K, Maier S, et al.

    Movement disorders : official journal of the Movement Disorder Society 2024; (39(3)):510-518 doi:10.1002/mds.29687.

    PMID: 38140802
  7. 7

    Ectopic Burden via Holter Monitors in Friedreich Ataxia.

    Mejia E, Lynch A, Hearle P, et al.

    Pediatric neurology 2021; (117()):29-33 doi:10.1016/j.pediatrneurol.2021.01.004.

    PMID: 33652339
  8. 8

    Significance of NT-proBNP and High-sensitivity Troponin in Friedreich Ataxia.

    Legrand L, Maupain C, Monin ML, et al.

    Journal of clinical medicine 2020; (9(6)) doi:10.3390/jcm9061630.

    PMID: 32481586
  9. 9

    The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement.

    Weidemann F, Liu D, Hu K, et al.

    International journal of cardiology 2015; (194()):50-7.

    PMID: 26005806
  10. 10

    Management of Friedreich Ataxia-Associated Cardiomyopathy in Pregnancy: A Review of the Literature.

    Peterson AN, Hickerson LC, Pschirrer ER, et al.

    The American journal of cardiology 2024; (210()):118-129 doi:10.1016/j.amjcard.2023.10.019.

    PMID: 37838071

This page is for informational purposes only and does not constitute medical advice. A cardiologist familiar with Friedreich ataxia should set your testing schedule and guide decisions about symptoms, pregnancy, and urgent care.